Back

Is there a need to revise the ESC Guidelines for myocardial revascularisation and chronic coronary syndromes because of the ISCHEMIA trial?

27 August 2021 (09:52 - 10:03)
Organised by:
Congress Presentation Part of: Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial Clinical ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Bernard Gersh

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
Beyond the ISCHEMIA paradigm: updating the role of stress tests, coronary CT and optimisation of medical therapy.
Assistant Professor S. Kohsaka (Tokyo, JP)
Slides Video
Presentation thumbnail
How should we manage chronic coronary syndromes after the ISCHEMIA trial?
Doctor F. Otsuka (Suita, JP)
Slides Video
Presentation thumbnail
Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.
Presentation thumbnail
Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial - Chat Moderator.

Access the full session

Session thumbnail
Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 09:52 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources